C. Ronald Kahn
Harvard University
H-index: 219
North America-United States
Description
C. Ronald Kahn, With an exceptional h-index of 219 and a recent h-index of 99 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Diabetes, Obesity, Insulin Action, Insulin Resistance.
His recent articles reflect a diverse array of research interests and contributions to the field:
Interactions among insulin resistance, epigenetics, and donor sex in gene expression regulation of iPSC-derived myoblasts
Retraction: Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of β1-Integrin and phosphatidylinositol 3′-kinase/AKT …
Loss of PKCδ/Prkcd prevents cartilage degeneration in joints but exacerbates hyperalgesia in an experimental osteoarthritis mouse model
Unique ligand and kinase-independent roles of the insulin receptor in regulation of cell cycle, senescence and apoptosis
190-OR: Lrtm1, a Novel Regulator of Insulin Signaling and Metabolism
292-OR: High-Fat Diets Containing Sucrose and Fructose, but Not Glucose, Induce Obesity and Hepatic Insulin Resistance via Accumulation of Diacylglycerols
Hepatic insulin receptor: new views on the mechanisms of liver disease
PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells
Professor Information
University | Harvard University |
---|---|
Position | Joslin Diabetes Center and Harvard Medical School |
Citations(all) | 188378 |
Citations(since 2020) | 42141 |
Cited By | 160886 |
hIndex(all) | 219 |
hIndex(since 2020) | 99 |
i10Index(all) | 810 |
i10Index(since 2020) | 440 |
University Profile Page | Harvard University |
Research & Interests List
Diabetes
Obesity
Insulin Action
Insulin Resistance
Top articles of C. Ronald Kahn
Interactions among insulin resistance, epigenetics, and donor sex in gene expression regulation of iPSC-derived myoblasts
About 25% of people in the general population are insulin resistant, increasing the risk for type 2 diabetes (T2D) and metabolic disease. Transcriptomic analysis of induced pluripotent stem cells differentiated into myoblasts (iMyos) from insulin-resistant (I-Res) versus insulin-sensitive (I-Sen) nondiabetic individuals revealed that 306 genes increased and 271 genes decreased in expression in iMyos from I-Res donors with differences of 2-fold or more. Over 30 of the genes changed in I-Res iMyos were associated with T2D by SNPs and were functionally linked to insulin action and control of metabolism. Interestingly, we also identified more than 1,500 differences in gene expression that were dependent on the sex of the cell donor, some of which modified the insulin resistance effects. Many of these sex differences were associated with increased DNA methylation in cells from female donors and were reversed by 5 …
Authors
Nida Haider,C Ronald Kahn
Journal
The Journal of Clinical Investigation
Published Date
2024/1/16
Retraction: Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of β1-Integrin and phosphatidylinositol 3′-kinase/AKT …
1. Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, et al. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of b1-integrin and phosphatidylinositol 3’-kinase/AKT signaling. Cancer Res 2003; 63: 5850–58.
Authors
Yu-Tzu Tai,Klaus Podar,Laurence Catley,Yu-Hua Tseng,Masaharu Akiyama,Reshma Shringarpure,Renate Burger,Teru Hideshima,Dharminder Chauhan,Nicholas Mitsiades,Paul Richardson,Nikhil C Munshi,C Ronald Kahn,Constantine Mitsiades,Kenneth C Anderson
Published Date
2024/3/15
Loss of PKCδ/Prkcd prevents cartilage degeneration in joints but exacerbates hyperalgesia in an experimental osteoarthritis mouse model
Pain is the prime symptom of osteoarthritis (OA) that directly affects the quality of life. Protein kinase Cδ (PKCδ/Prkcd) plays a critical role in OA pathogenesis; however, its significance in OA-related pain is not entirely understood. The present study investigated the functional role of PKCδ in OA pain sensation. OA was surgically induced in control (Prkcdfl/fl), global- (Prkcdfl/fl; ROSACreERT2), and sensory neuron-specific conditional knockout (cKO) mice (Prkcdfl/fl; NaV1.8/Scn10aCreERT2) followed by comprehensive analysis of longitudinal behavioral pain, histopathology and immunofluorescence studies. Global Prkcd cKO mice prevented cartilage deterioration by inhibiting matrix metalloproteinase-13 (MMP13) in joint tissues but significantly increased OA pain. Sensory neuron-specific deletion of Prkcd in mice did not protect cartilage from degeneration but worsened OA-associated pain. Exacerbated pain …
Authors
Gurjit Singh,O InSug,Arivarasu Natarajan Anbazhagan,KC Ranjan,Zeba Farooqui,Kaige Ma,Jun Wang,Fackson Mwale,Gina Votta-Velis,Benjamin Bruce,C Ronald Kahn,Andre J van Wijnen,Hee-Jeong Im
Journal
Gene
Published Date
2024/1/30
Unique ligand and kinase-independent roles of the insulin receptor in regulation of cell cycle, senescence and apoptosis
Insulin acts through the insulin receptor (IR) tyrosine kinase to exert its classical metabolic and mitogenic actions. Here, using receptors with either short or long deletion of the β-subunit or mutation of the kinase active site (K1030R), we have uncovered a second, previously unrecognized IR signaling pathway that is intracellular domain-dependent, but ligand and tyrosine kinase-independent (LYK-I). These LYK-I actions of the IR are linked to changes in phosphorylation of a network of proteins involved in the regulation of extracellular matrix organization, cell cycle, ATM signaling and cellular senescence; and result in upregulation of expression of multiple extracellular matrix-related genes and proteins, down-regulation of immune/interferon-related genes and proteins, and increased sensitivity to apoptosis. Thus, in addition to classical ligand and tyrosine kinase-dependent (LYK-D) signaling, the IR regulates a …
Authors
Hirofumi Nagao,Ashok Kumar Jayavelu,Weikang Cai,Hui Pan,Jonathan M Dreyfuss,Thiago M Batista,Bruna B Brandão,Matthias Mann,C Ronald Kahn
Journal
Nature Communications
Published Date
2023/1/4
190-OR: Lrtm1, a Novel Regulator of Insulin Signaling and Metabolism
GUOXIAO WANG, YINGYING YU, WENQIANG CHEN, WEIKANG CAI, XIANGYU LIU, C. RONALD KAHN; 190-OR: Lrtm1, a Novel Regulator of Insulin Signaling and Metabolism. Diabetes 20 June 2023; 72 (Supplement_1): 190–OR. https://doi. org/10.2337/db23-190-OR
Authors
GUOXIAO WANG,YINGYING YU,WENQIANG CHEN,WEIKANG CAI,XIANGYU LIU,C RONALD KAHN
Journal
Diabetes
Published Date
2023/6/20
292-OR: High-Fat Diets Containing Sucrose and Fructose, but Not Glucose, Induce Obesity and Hepatic Insulin Resistance via Accumulation of Diacylglycerols
Diets high in sugar and fat promote the development of obesity and metabolic complications, while high-sugar, low-fat or high-fat, sugar-free (ketogenic) diets do not. We assessed the importance of sugar in a commonly used 60% high-fat diet (HFD), which contains 6.7% of calories from sucrose. The sucrose content was replaced either with an equal amount of fructose (HFD+ RF) or glucose (HFD+ RG) and all other components of the diet were identical. After 12 weeks on the diets, the mice on HFD and HFD+ RF diets gained more weight, developed hepatic steatosis, glucose intolerance and insulin resistance, compared to the mice on normal chow or HFD+ RG diets. A relatively small (6.7%) amount of sucrose or fructose, but not glucose, in a HFD was sufficient to increase the fructolysis (KHK-C, ALDO B and TKFC) and de novo lipogenesis (ME1, ACLY, ACC1, FASN, SCD1) pathways by WB. Metabolomics …
Authors
SE-HYUNG PARK,TAGHREED I FADHUL,C RONALD KAHN,SAMIR SOFTIC
Journal
Diabetes
Published Date
2023/6/20
Hepatic insulin receptor: new views on the mechanisms of liver disease
Over 65 % of people with obesity display the metabolic-associated fatty liver disease (MAFLD), which can manifest as steatohepatitis, fibrosis, cirrhosis, or liver cancer. The development and progression of MAFLD involve hepatic insulin resistance and reduced insulin clearance. This review discusses the relationships between altered insulin signaling, hepatic insulin resistance, and reduced insulin clearance in the development of MAFLD and how this provides the impetus for exploring the use of insulin sensitizers to curb this disease. The review also explores the role of the insulin receptor in hepatocytes and hepatic stellate cells and how it signals in metabolic and end-stage liver diseases. Finally, we discuss new research findings that indicate that advanced hepatic diseases may be an insulin-sensitive state in the liver and deliberate whether insulin sensitizers should be used to manage late-stage liver diseases.
Authors
Wang-Hsin Lee,Sonia M Najjar,C Ronald Kahn,Terry D Hinds Jr
Published Date
2023/6/2
PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells
Secondary lymphedema occurs in up to 20% of patients after lymphadenectomy performed for the surgical management of tumors involving the breast, prostate, uterus, and skin. Patients develop progressive edema of the affected extremity due to retention of protein-rich lymphatic fluid. Despite compression therapy, patients progress to chronic lymphedema in which noncompressible fibrosis and adipose tissue are deposited within the extremity. The presence of fibrosis led to our hypothesis that rosiglitazone, a PPARγ agonist that inhibits fibrosis, would reduce fibrosis in a mouse model of secondary lymphedema after hind limb lymphadenectomy. In vivo, rosiglitazone reduced fibrosis in the hind limb after lymphadenectomy. Our findings verified that rosiglitazone reestablished the adipogenic features of TGF-β1–treated mesenchymal cells in vitro. Despite this, rosiglitazone led to a reduction in adipose tissue …
Authors
Ziyu Chen,Soheila Ali Akbari Ghavimi,Mengfan Wu,John McNamara,Olga Barreiro,David Maridas,Radomir Kratchmarov,Ashley Siegel,Sarah Djeddi,Maria Gutierrez-Arcelus,Patrick J Brennan,Timothy P Padera,Ulrich von Andrian,Babak Mehrara,Arin K Greene,C Ronald Kahn,Dennis P Orgill,Indranil Sinha,Vicki Rosen,Shailesh Agarwal
Journal
JCI insight
Published Date
2023/12/12
Professor FAQs
What is C. Ronald Kahn's h-index at Harvard University?
The h-index of C. Ronald Kahn has been 99 since 2020 and 219 in total.
What are C. Ronald Kahn's top articles?
The articles with the titles of
Interactions among insulin resistance, epigenetics, and donor sex in gene expression regulation of iPSC-derived myoblasts
Retraction: Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of β1-Integrin and phosphatidylinositol 3′-kinase/AKT …
Loss of PKCδ/Prkcd prevents cartilage degeneration in joints but exacerbates hyperalgesia in an experimental osteoarthritis mouse model
Unique ligand and kinase-independent roles of the insulin receptor in regulation of cell cycle, senescence and apoptosis
190-OR: Lrtm1, a Novel Regulator of Insulin Signaling and Metabolism
292-OR: High-Fat Diets Containing Sucrose and Fructose, but Not Glucose, Induce Obesity and Hepatic Insulin Resistance via Accumulation of Diacylglycerols
Hepatic insulin receptor: new views on the mechanisms of liver disease
PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells
...
are the top articles of C. Ronald Kahn at Harvard University.
What are C. Ronald Kahn's research interests?
The research interests of C. Ronald Kahn are: Diabetes, Obesity, Insulin Action, Insulin Resistance
What is C. Ronald Kahn's total number of citations?
C. Ronald Kahn has 188,378 citations in total.